[Effect of levamisole on the course of chronic cytomegalovirus infection in women].
The therapeutic effect of orally given levamisole in the treatment of women with chronic cytomegalovirus infection was studied. The patients were examined serologically, cytologically, virologically; the factors of cell-mediated immunity were also studied. Oral therapy with levamisole resulted in a definite increase of the cell-mediated immunity with a trend for decrease in antibody titres and reduced virus excretion. Evaluation of the clinical effect of levamisole therapy, however, revealed no distinct difference in the outcomes of pregnancy in the groups of women treated or not treated with levamisole.
D000276:Adjuvants, Immunologic; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D002908:Chronic Disease; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use*; D007744:Obstetric Labor Complications / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007978:Levamisole
Vliianie levamizola na techenie khronicheskoĭ tsitomegalovirusnoĭ infektsii u zhenshchin.